Zoledronic acid does not affect insulin resistance in men receiving androgen deprivation therapy: a prespecified secondary analysis of a randomised controlled trial.
Ingrid BrethertonRudolf HoermannJasmine ZhuDaryl Lim JoonJeffrey D ZajacMathis GrossmannPublished in: Therapeutic advances in endocrinology and metabolism (2021)
[ClinicalTrials.gov identifier: NCT01006395].